Developed, owned and marketed by Hyphens Pharma, Ceradan^® was realised on the premise of a simple idea that Asians can improve the world’s healthcare.

We believe that innovation in healthcare products can come from within Asia.

In 2011, Hyphens Pharma launched a single product – Ceradan^®, the novel ceramide-dominant skin barrier repair cream that replenishes the skin’s physiological lipids (ceramide, cholesterol and free fatty acids) in an optimal ratio of 3:1:1.

At Hyphens Pharma, one of our dedications is dermatology work. What continues to drive us is our commitment to improving the lives of patients living with skin disorders.

Since then, we have expanded the Ceradan^® range of products, as well as another proprietary range of dermatological products marketed under the TDF^® brand.

Leveraging on our knowledge and network in the specialty pharmaceutical principals segment, Hyphens Pharma has built trusted brands and relationships with the medical and scientific community throughout the years, working together in research and clinical collaborations to deliver advanced skin care products.

In addition to the Ceradan^® and TDF^® brands, we also own a proprietary range of health supplement products marketed under the Ocean Health^® brand.

Hyphens Pharma is a part of Hyphens Group.

Hyphens Pharma International Limited (SGX: 1J5.Bloomberg: HYP:SP) and its subsidiaries (the “Group”) is Singapore’s leading specialty pharmaceutical and consumer healthcare group, listed on the Catalist board of the Singapore Exchange (SGX).

For more information, please visit:
Hyphens Pharma: www.hyphens.com.sg
Hyphens Group : www.hyphensgroup.com